AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.
AZN Key Statistics
Stock Snapshot
The current AstraZeneca(AZN) stock price is $169.66, with a market capitalization of 263.17B. The stock trades at a price-to-earnings (P/E) ratio of 25.26 and offers a dividend yield of 1.86%.
As of 2026-07-28, AstraZeneca(AZN) stock has fluctuated between $167.79 and $173.22. The current price stands at $169.66, placing the stock +1.1% above today's low and -2.1% off the high.
The AstraZeneca(AZN)'s current trading volume is 3.86M, compared to an average daily volume of 2.6M.
During the past year, AstraZeneca(AZN) stock moved between $142.98 at its lowest and $212.71 at its peak.
During the past year, AstraZeneca(AZN) stock moved between $142.98 at its lowest and $212.71 at its peak.
AZN News
Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...
Yves Herman / Reuters The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET....
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confi...
Analyst ratings
77%
of 31 ratingsMore AZN News
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident...
Healthcare investors are watching AstraZeneca closely after fresh comments about operating at Chinese speed, reaffirming a 2030 sales goal of $80b and reporting...
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 400 points on Monday. Following the market opening Monday, the Dow traded up...
10:11 EDT Omeros (OMER) up 11% to $10.89 after AstraZeneca (AZN) study failure Published first on TheFly – the ultimate source for real-time, market-moving bre...
AstraZeneca Beats Earnings Estimates, Misses Revenue Expectations The company posted revenue of $15.384 billion, up 6% year over year, or 5% at constant curren...
Analyst Sachin Jain from Bank of America Securities reiterated a Buy rating on AstraZeneca and keeping the price target at p16,500.00. Unlock powerful investin...
(RTTNews) - British drug major AstraZeneca PLC reported Monday lower pre-tax pofit in its second quarter mainly on lower tax expenses, while earnings per share...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.